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Background: Gastrointestinal tract microbiota, particularly bacterial microflora, seem to have a different qualitative
and quantitative composition in both type 1 (T1DM) and type 2 diabetes (T2DM) mellitus cases as compared to
non-diabetic individuals. So far, there are no data from diabetes research concerning the prevalence of fungi,
particularly the most common genus, i.e. Candida, which are important components of human colon microflora.
We aimed to examine whether there are quantitative changes of Candida fungi in the feces of patients with
T1DM and T2DM as compared to healthy controls.
Findings: Overall, we included 44 diabetic patients (27 patients with T1DM and 17 with T2DM) as well as 17 healthy,
non-diabetic controls. Feces and blood samples were collected from all study individuals. DNA was isolated from fecal
samples and quantitative real time PCR (qPCR) was applied in order to determine the number of fungal cells. Statistical
association with selected clinical and biochemical features was examined.
There was a difference in the amount of Candida in the feces among the three examined groups (p = 0.007). Candida
spp. populations in T1DM and T2DM subjects were larger as compared to controls (p = 0.017 and p = 0.037, respectively).
However, no difference was found between T1DM and T2DM. No association was identified between the quantity of
fungi and examined patients’ characteristics, except for negative correlation with blood lipid parameters in T2DM group.
Conclusions: Candida fungi appear to be more prevalent in the feces of patients with T1DM and T2DM. Their amount
seems to be associated with serum lipids in T2DM patients. This initial finding requires further confirmation.
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Globally, the total number of patients with both type 1
(T1DM) and type 2 diabetes (T2DM) has reached epidemic
proportions. This creates enormous problems linked to
health, economics and society around the world. Identi-
fication of all factors influencing the occurrence of T1DM
and T2DM as well as modifying its clinical course is of
great scientific and clinical importance. One of such
possible factors are bacterial and fungal microbiota of
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unless otherwise stated.example, the speed of decomposition of complex food
components [1,2]. Thus, they may potentially influence
pathogenesis of T1DM, as the evidence exists that pro-
cesses of digestion and absorption modify the occurrence
of autoagression, a major factor underlying this disease
[3]. Gastrointestinal tract microbiota have also been linked
with obesity, that is strongly associated with pathogenesis
of T2DM [4]. Finally, the speed of digestion and absorption
of carbohydrates substantially influences glucose levels
in patients with diabetes [5]. Thus, determining changes in
the composition of the gastrointestinal tract microbiota in
the course of natural history of T1DM and T2DM could
be potentially useful for developing preventive and thera-
peutic measures, for example through the use of probiotics.ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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e.g., irritable bowel syndrome [6].
So far, some studies on changes in the bacterial micro-
flora of the human gastrointestinal tract in the course of
diabetes have been published. However, there are not
enough data from diabetes research concerning fungi,
particularly those entailing the most prevalent genus,
Candida, which is an important component of human
colonic microflora.
In the current study, we aimed to examine whether
there are quantitative changes of Candida fungi in the
feces of patients with T1DM and T2DM as compared to
the healthy controls.
Materials and methods
Patients
Overall, we included 44 diabetic patients (27 patients
with T1DM and 17 with T2DM) as well as 17 healthy
non-diabetic controls. Their characteristics are provided
in Table 1; all the subjects were white Caucasians, resi-
dents of south-eastern Poland. The patients with diabetes
remained under medical care of the Department of Meta-
bolic Diseases, University Hospital, Krakow, Poland.
T1DM patients had a clinical diagnosis of this type of
diabetes, their insulin therapy was implemented in the first
year following diagnosis and disease duration was at least
2 years. T2DM patients, in addition to a clinical diagnosis
of non-insulin dependent diabetes, must have been on
oral hypoglycemic agents for least 2 years following theTable 1 Characteristics of the studied patient groups
T1DM T2DM Control
Male : Female (n) 10 : 17 7 : 10 5 : 12
27 17 17
Age* (yrs) 35.50 & 57.43# 41.12
(±7.72) (±7.39) (±8.49)
duration of
diabetes* (yrs)
12.61# 9.29# 0.0
(±9.04) (±5.04) (±0.0)
BMI* [kg/m2] 24.18 ± 3.61& 30.91 ± 4.73# 22.94 ± 1.4
glucose* [mmol/l] 7.17 ± 1.35# 7.07 ± 1.03# 4.73 ± 0.4
total cholesterol
[mmol/l]
4.78 ± 0.79 4.63 ± 0.92 5.37 ± 0.53
HDL* [mmol/l] 1.60 ± 0.25& 1.05 ± 0.22# 1.76 ± 0.25
LDL [mmol/l] 2.74 ± 0.62 2.85 ± 0.83 3.21 ± 0.5
triglycerides
(TG)* [mmol/l]
1.09 ± 0.45& 1.80 ± 0.58# 0.93 ± 0.33
HbA1c* [%] 8.90 ± 1.89# 9.00 ± 1.74# 5.44 ± 0.26
The presented data are means ± SD.
*significant differences within the three compared groups of patients
(p < 0.05) – Kruskal–Wallis test.
#significant differences between the examined group of patients and the
controls (p < 0.05) – Mann–Whitney U Test.
&significant differences between the examined groups of patients (T1DM vs.
T2DM) (p < 0.05) – Mann–Whitney U Test.diagnosis, their disease duration was 2 years or more. The
control group consisted of apparently healthy non-diabetic
subjects. Basic clinical data, such as diabetes duration (for
T1DM and T2DM groups), age at the examination, weight
and height were collected. We excluded all individuals
who were treated with antibiotics or were using pro-
biotic preparations during the period of 30 days before
collecting the feces samples. Other exclusion criteria
included confirmed infections of the gastrointestinal tract,
chronic inflammatory bowel diseases, neoplasms and im-
munodeficiency syndromes.
The study was approved by the Jagiellonian University
Bioethical Committee. Informed consent was provided by
all patients.
Samples
Feces and blood samples were collected from all patients
participating in the study. Using the blood samples, the
following parameters were determined: lipid profile (HDL,
LDL, total cholesterol, triglycerides), glycated hemoglobin
(HbA1c) and serum fasting glucose levels. Feces samples
were transported under deep-freezing conditions to the
microbiological laboratory where DNA was extracted ac-
cording to the previously described procedure [7].
Quantitative real time PCR (qPCR)
Candida spp. in the fecal samples were quantified by
qPCR. To detect Candida DNA, JumpStart Taq ReadyMix
for Quantitative PCR kit (Sigma), TaqMan probe (FAM-
5′-TTAACCTACTAAATAGTGCTGCTAGC-BHQ1-3′)
and pairs of specific primers (5′-TTGGTGGAGTGAT
TTGTCTGCT-3′; 5′-TCTAAGGGCATCACAGACCT
G-3′) were used (Genomed) [8]. A standard curve was
prepared. DNA from C. albicans ATCC10231 was added in
serial dilutions corresponding to 101 to 107 cells to a series
of qPCRs. The reactions were carried out on a CFX96
thermocycler (BioRad). The results are shown in (Figure 1).
To determine the number of Candida cells, the fluores-
cent signals detected in DNA feces samples (in duplicate)
in the linear range of the assay were averaged and com-
pared to the standard curve (Figure 2).
Statistical analysis
The comparisons were made using the Kruskal–Wallis
Test to describe the total distribution (in patient groups
and the controls) of the studied parameters, including the
number of Candida cells. The Mann–Whitney U test was
used to analyze differences between the T1DM and T2DM
patient groups and controls. Correlations between num-
bers of Candida spp. and age, diabetes duration, BMI, as
well as biochemical features, in the examined groups were
assessed using the Spearman Rho correlation coefficient.
The value p < 0.05 was regarded as the threshold for
statistical significance. All data analysis was performed
Figure 1 Relative fluorescence units is the increase in reporter FAM dye intensity relative to the passive internal reference dye. The
amount of C. albicans ATCC10231 DNA in each sample is shown in the chart. The threshold fluorescence, or level at which the threshold cycle
was determined, is shown.
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(SAS Institute, USA).
Results
Clinical characteristics of the examined study group are
shown in Table 1. The presence of Candida DNA was
assessed quantitatively by qPCR (Figures 1 and 2). The
identified differences between the groups in respect to
the age, T1DM duration, BMI and glycemic control were
in line with the way the groups were defined.
There was a difference in the amount of Candida in the
feces among the three examined groups (p = 0.007).
Candida spp. populations in T1DM and T2DM subjects
were larger as compared to controls (p = 0.017 and p =
0.037, respectively). However, no difference was found be-
tween T1DM and T2DM (Figure 3).
No association was identified between the quantity of
fungi and the examined characteristics within the indi-
vidual study groups, except for negative correlation withFigure 2 Standard curve was generated from the amplification plot in
Threshold cycle was the cycle number when the threshold fluorescence wblood lipid parameters: total cholesterol (ρ = -0.770, p =
0.03), HDL (ρ = -0.934, p = 0.002), LDL (ρ = -0.830, p =
0.016) and triglycerides (ρ = -0.755, p = 0.035) in T2DM
patient group.
Discussion
This is perhaps the first study wherein we e demonstrate
occurrence of a larger number of Candida fungi in the
feces of patients with diabetes as compared to the control
group.
The genus Candida belongs to the microbiota group
that is normally present in the gastrointestinal tract. There
are some reports of associations between the occurrence
of symptomatic infections caused by fungi of the genus
Candida (candidiasis) and diabetes mellitus [9]. However,
there is a clear lack of studies on the presence or occur-
rence of Candida spp. in the colon during the course
of T1DM and T2DM in different patient populations ex-
cept a lone study conducted using microbiological cultureFigure 1. y = -1.413ln(x) + 39.985; correlation coefficient (R2) = 0.9866.
as reached.
Figure 3 Quantitative evaluation of fungi of the genus Candida in the feces of patients with T1DM, T2DM and control using qPCR
method: # significant differences between the examined group of patients and the controls (p < 0.05); there was a difference in the
amount of Candida in the feces among the three examined groups (p = 0.007).
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characterized by increased number of Candida as com-
pared with the control non-diabetic individuals.
Our results suggest that in diabetic patients the col-
onization of the colon by Candida fungi is more promin-
ent than in people without diabetes. In our opinion, the
differences in the number of Candida in the studied
groups are very unlikely to be associated with patho-
genesis of diabetes, but are probably secondary to dia-
betes. One of the potential reasons could be related to
an altered function of the immune system in diabetic
patients with poor glycemic control, such as in our co-
hort. The other putative cause may be a direct effect of
elevated blood glucose levels creating specific conditions
for intensive fungal colonization. Although, in this study,
no association was demonstrated between the level of
blood glucose and the number of fungi, there was already
a published study showing such a correlation [11]. How-
ever, in this earlier research, the samples comprising rectal
swabs were taken only from women and analyzed with
semi-quantitative evaluation of the number of Candida
cells by microbiological culture methods [11]. Evaluation
of the feces samples by qPCR method is much more
reliable.
Our data suggest existence of a negative correlation be-
tween the number of Candida cells in the large intestines
and the levels of serum lipids, such as total cholesterol,
HDL, LDL and triglycerides in T2DM subjects. This is the
first such observation made in humans. However, there
are some studies performed in vitro that examined the
relationships between fungi and lipids. For example,
triglyceride-hydrolyzing lipase isolated from the Candidaviswanathii fungal strain of natural origin reduced the con-
centration of triglycerides [12]. Another study has reported
that some species of fungi of the genus Saccharomyces
(related to Candida), demonstrated the ability to reduce the
concentration of cholesterol in the culture medium [13].
The above findings may suggest that the genus Candida can
also affect the levels of lipids in the colonized host. The
mechanism may be related to the decomposition of these
substances in the gastrointestinal tract, which reduces their
absorption. Such properties have been proved in certain
strains of probiotic bacteria, commonly used as dietary
supplements or drugs [14,15]. These studies suggest that
bacteria are capable of mediating reduction of lipid
concentration in the host organism, therefore, analogous
properties could potentially be attributed to at least some
species of fungi comprising the colon microbiota. This
claim requires further, more detailed experiments involv-
ing isolation of specific fungi from the collected fecal
samples, followed by a series of in vitro tests, enabling
identification of the strains which have the described
properties. It is puzzling why we failed to demonstrate
any correlation between the number of Candida in the
large intestine of patients with T1DM and the control
group and the lipid levels. Perhaps there were not enough
fungal cells in the T1DM group to cause such an effect,
although, differences between these groups were not
significant. It is also possible that in the T2DM group
there were other types of Candida strains capable of lipid
degradation. This could have been related to higher BMI in
T2DM as compared to the T1DM group and the control.
A higher BMI suggests increased fat content in patients’
diet, which may influence increase in the level of digestive
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down lipids. The obtained results are preliminary and
require confirmation on a larger number of patients. The
list of limitations of the current study includes single-point
examination, limited sample size of the study groups and
inclusion of only individuals with relatively long course of
diabetes. Thus, our observations might require further
confirmation.
Conclusion
Candida fungi appear to be more prevalent in the feces
of patients with T1DM and T2DM with poor glycemic
control than in individuals without diabetes. Their amount
seems inversely correlated with the serum lipids in T2DM.
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